Leah Aluisio - Concepedia

Author

Leah Aluisio

Johnson & Johnson (United States)

Also Known As

L Aluisio, L. Aluisio, Leah Aluisio, Leah E Aluisio, Leah E. Aluisio

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Johnson & Johnson (United States)Janssen (United States)Janssen (Belgium)Inscopix (United States)

About

Leah Aluisio is an author at Johnson & Johnson (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	19	1.2K
2	Biochemistry	9	9	566
3	Social Sciences	5	5	257
4	Natural Sciences	2	2	53
5	Allergy	2	2	161

Leah Aluisio

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression Ewa Wajs, Leah Aluisio, Richard Holder, The Journal of Clinical Psychiatry	2020	261
Blockade of Orexin-1 Receptors Attenuates Orexin-2 Receptor Antagonism-Induced Sleep Promotion in the Rat Christine Dugovic, Jonathan Shelton, Leah Aluisio, Journal of Pharmacology and Experimental Therapeutics	2009	228
Pharmacological characterization of a novel centrally permeable <scp>P2X7</scp> receptor antagonist: <scp>JNJ</scp>‐47965567 Anindya Bhattacharya, Qi Wang, Hong Ao, British Journal of Pharmacology	2013	191
Selective Blockade of 5-Hydroxytryptamine (5-HT)7 Receptors Enhances 5-HT Transmission, Antidepressant-Like Behavior, and Rapid Eye Movement Sleep Suppression Induced by Citalopram in Rodents Pascal Bonaventure, Lisa A. Kelly, Leah Aluisio, Journal of Pharmacology and Experimental Therapeutics	2007	163
Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement James R. Shoblock, Natalie Welty, Leah Aluisio, Psychopharmacology Selective BlockadeOrexin-2 ReceptorFunctional SelectivityAddictionMedicine	2010	156
Acute wake‐promoting actions of JNJ‐5207852, a novel, diamine‐based H<sub>3</sub> antagonist Ann Barbier, Craig W. Berridge, Christine Dugovic, British Journal of Pharmacology Molecular PharmacologyMolecular PhysiologyPharmacological StudyBiochemistryH3 Receptor Antagonist	2004	141
Histamine H3 receptor antagonists: From target identification to drug leads Pascal Bonaventure, Michael A. Letavic, Christine Dugovic, Biochemical Pharmacology Drug TargetAllergyBiochemistryFunctional SelectivityMedicine	2006	134
Translational Evaluation of JNJ-18038683, a 5-Hydroxytryptamine Type 7 Receptor Antagonist, on Rapid Eye Movement Sleep and in Major Depressive Disorder Pascal Bonaventure, Christine Dugovic, Michelle Kramer, Journal of Pharmacology and Experimental Therapeutics	2012	83
Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia Pascal Bonaventure, Jonathan Shelton, Sujin Yun, Journal of Pharmacology and Experimental Therapeutics	2015	80
Novel substituted 4-phenyl-[1,3]dioxanes: potent and selective orexin receptor 2 (OX2R) antagonists Laura C. McAtee, Steven W. Sutton, Dale A. Rudolph, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistryFunctional SelectivityMedicineMechanism Of Action	2004	78

Page 1